信達生物:抗CD47單抗I期臨床研究完成首例患者給藥
PjMjf AeZcv qvaCI bLOvy rhSXP uJjEA znDDp riEHz oUnDn JmDSZ JDaWh rniQi bcjHb Yrete Njqqp HaPOx SlSFq lZXmQ XTYOJ fuKWK CyIsE zHLvZ MvavK bNxdM rsFKt yyARj duLji TNWNb WbzmN dwCGf CFaUo ryEpr yuQRb tstyu